180 related articles for article (PubMed ID: 35177056)
1. The relationship between peak inspiratory flow and hand grip strength measurement in men with mild chronic obstructive pulmonary disease.
Tsuburai T; Komase Y; Tsuruoka H; Oyama B; Muraoka H; Hida N; Kobayashi T; Matsushima S
BMC Pulm Med; 2022 Feb; 22(1):65. PubMed ID: 35177056
[TBL] [Abstract][Full Text] [Related]
2. Association between peak inspiratory flow rate and hand grip muscle strength in hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease.
Samarghandi A; Ioachimescu OC; Qayyum R
PLoS One; 2020; 15(1):e0227737. PubMed ID: 32004333
[TBL] [Abstract][Full Text] [Related]
3. Physiological predictors Of peak inspiRatory flow using Observed lung function resultS (POROS): evaluation at discharge among patients hospitalized for a COPD exacerbation.
Price DB; Yang S; Ming SWY; Hardjojo A; Cabrera C; Papaioannou AI; Loukides S; Kritikos V; Bosnic-Anticevich SZ; Carter V; Dorinsky PM
Int J Chron Obstruct Pulmon Dis; 2018; 13():3937-3946. PubMed ID: 30587952
[TBL] [Abstract][Full Text] [Related]
4. Inspiratory flow rates at different levels of resistance in elderly COPD patients.
Janssens W; VandenBrande P; Hardeman E; De Langhe E; Philps T; Troosters T; Decramer M
Eur Respir J; 2008 Jan; 31(1):78-83. PubMed ID: 17898020
[TBL] [Abstract][Full Text] [Related]
5. [Peak inspiratory flow generated through different analogue dry powder inhalers in Shenzhen healthy preschool children].
Zhang QL; Zheng JP; Pan WH; He H; Chen GL; An JY; Yuan LF; Luo DF
Zhonghua Er Ke Za Zhi; 2008 Feb; 46(2):98-103. PubMed ID: 19099680
[TBL] [Abstract][Full Text] [Related]
6. [The variability of peak inspiratory flow (PIF) on valves imitating dry powder inhalers resistance during asthma and COPD exacerbations].
Grabowski M; Barg W; Chmielowicz B; Kopeć A; Panaszek B
Pneumonol Alergol Pol; 2007; 75(4):324-30. PubMed ID: 18080981
[TBL] [Abstract][Full Text] [Related]
7. Comparison of peak inspiratory flow rate via the Breezhaler®, Ellipta® and HandiHaler® dry powder inhalers in patients with moderate to very severe COPD: a randomized cross-over trial.
Altman P; Wehbe L; Dederichs J; Guerin T; Ament B; Moronta MC; Pino AV; Goyal P
BMC Pulm Med; 2018 Jun; 18(1):100. PubMed ID: 29898702
[TBL] [Abstract][Full Text] [Related]
8. Inspiratory Flow Parameters Through Dry Powder Inhalers in Healthy Volunteers and Patients with Chronic Obstructive Pulmonary Disease (COPD): Device Resistance Does Not Limit Use in COPD.
Jõgi R; Mattila L; Vahteristo M; Takala A; Lähelmä S; Vartiainen VA; Lindqvist A
Int J Chron Obstruct Pulmon Dis; 2021; 16():1193-1201. PubMed ID: 33958863
[TBL] [Abstract][Full Text] [Related]
9. Lung characteristics in elderly males and females patients with COPD: differences and optimal use of dry powder inhalers (DPIs).
Terzano C; Oriolo F
Eur Rev Med Pharmacol Sci; 2017 Jun; 21(11):2708-2716. PubMed ID: 28678314
[TBL] [Abstract][Full Text] [Related]
10. Inspiratory muscle training may increase peak inspiratory flow in chronic obstructive pulmonary disease.
Weiner P; Weiner M
Respiration; 2006; 73(2):151-6. PubMed ID: 16155355
[TBL] [Abstract][Full Text] [Related]
11. Inhaled therapy in elderly COPD patients; time for re-evaluation?
Jarvis S; Ind PW; Shiner RJ
Age Ageing; 2007 Mar; 36(2):213-8. PubMed ID: 17267450
[TBL] [Abstract][Full Text] [Related]
12. Suboptimal Inspiratory Flow Rates Are Associated with Chronic Obstructive Pulmonary Disease and All-Cause Readmissions.
Loh CH; Peters SP; Lovings TM; Ohar JA
Ann Am Thorac Soc; 2017 Aug; 14(8):1305-1311. PubMed ID: 28406710
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and predictors of suboptimal peak inspiratory flow rate in COPD patients.
Harb HS; Laz NI; Rabea H; Abdelrahim MEA
Eur J Pharm Sci; 2020 Apr; 147():105298. PubMed ID: 32151707
[TBL] [Abstract][Full Text] [Related]
14. Inhalation profiles in asthmatics and COPD patients: reproducibility and effect of instruction.
Broeders ME; Molema J; Hop WC; Folgering HT
J Aerosol Med; 2003; 16(2):131-41. PubMed ID: 12823907
[TBL] [Abstract][Full Text] [Related]
15. Establishment of relationships between native and inhalation device specific spirometric parameters as a step towards patient tailored inhalation device selection.
Farkas Á; Szipőcs A; Horváth A; Horváth I; Gálffy G; Varga J; Galambos K; Kugler S; Nagy A; Szalai Z
Respir Med; 2019; 154():133-140. PubMed ID: 31252206
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and factors associated with suboptimal peak inspiratory flow rates in COPD.
Ghosh S; Pleasants RA; Ohar JA; Donohue JF; Drummond MB
Int J Chron Obstruct Pulmon Dis; 2019; 14():585-595. PubMed ID: 30880948
[TBL] [Abstract][Full Text] [Related]
17. Peak Inspiratory Flow Rate in COPD: An Analysis of Clinical Trial and Real-World Data.
Anderson M; Collison K; Drummond MB; Hamilton M; Jain R; Martin N; Mularski RA; Thomas M; Zhu CQ; Ferguson GT
Int J Chron Obstruct Pulmon Dis; 2021; 16():933-943. PubMed ID: 33883890
[TBL] [Abstract][Full Text] [Related]
18. Peak Inspiratory Flows: Defining Repeatability Limits and a Predictive Equation for Different Inhalers.
Barnes CN; Mahler DA; Ohar JA; Lombardi DA; Crater GD
Chest; 2020 Oct; 158(4):1413-1419. PubMed ID: 32343967
[TBL] [Abstract][Full Text] [Related]
19. The inhalation characteristics of patients when they use different dry powder inhalers.
Azouz W; Chetcuti P; Hosker HS; Saralaya D; Stephenson J; Chrystyn H
J Aerosol Med Pulm Drug Deliv; 2015 Feb; 28(1):35-42. PubMed ID: 24815999
[TBL] [Abstract][Full Text] [Related]
20. Reduced Peak Inspiratory Effort through the Diskus((R)) and the Turbuhaler((R)) due to Mishandling is Common in Clinical Practice.
Melani AS; Bracci LS; Rossi M
Clin Drug Investig; 2005; 25(8):543-9. PubMed ID: 17532698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
